News ArchivesRead News

Your Parkinson's News Update for the Week of 9/14/20

Monday September 14, 2020
Living with Parkinson's in the NW: How to Plan for Wildfire Smoke
NW Parkinson's ft. Dr. Sverre Vedal
Last summer, NW Parkinson's shared this informational interview with Northwest pulmonary Doctor Sverre Vedal. As we face new smoke events from wildfires, we invite you to read this free article for a wide-ranging set of answers to many smoke-related questions and concerns. Dr. Vedal offers a variety of helpful strategies and understandings, including tools to check forecasts of wildfire smoke and Parkinson's-specific recommendations.
Brain Astrocytes Show Metabolic Alterations in Parkinson's
Scientific Reports via Medical Express
Astrocytes are glial cells and the most abundant cell type in the human brain: a new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson's pathology. The study carried out at the University of Eastern Finland and published in Scientific Reports highlights the role of brain astrocyte cells in Parkinson's pathology and the potential of iPSC-derived cells in disease modeling and drug discovery.
It was long thought that the astrocytes worked solely as supporting cells for neurons, but today the role of astrocytes is known to be far more extensive. Until now, only a few studies have used iPSC-derived astrocytes obtained from people with Parkinson's; this new research focus opens up new possibilities for understanding of Parkinson's and possible treatment.
Scientists Look to Cell Recycling Tools for
New Ways to Treat Parkinson's
Stem Cell Reports via Medical Xpress
Researchers at Johns Hopkins Medicine are taking a closer look at the molecular machinery that recycles mitochondria, the cell's powerhouse, in efforts to ramp up the production of the energy-producing structures. Problems with mitochondria are a key aspect in the development of Parkinson's.
To study neurons associated with the disorder, scientific tools have recently been developed, including mechanisms that foucs on genes related to Parkinson's. "Targeting [these areas anew] with drugs to lower its protein levels may provide a new way to treat Parkinson's."